WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001083724) A NEW POLYPEPTIDE - HUMAN DIHYDROORATASE 17 AND THE POLYNUCLEOTIDE ENCODING IT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/083724    International Application No.:    PCT/CN2001/000633
Publication Date: 08.11.2001 International Filing Date: 28.04.2001
IPC:
A61K 38/00 (2006.01), C12N 9/86 (2006.01)
Applicants: SHANGHAI BIOWINDOW GENE DEVELOPMENT INC. [CN/CN]; 12F, 3rd Building, No. 1111 Zhongshan Bei Er Rd, Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI HUA DONG PATENT AGENCY; 319 Yue Yang Road, Shanghai 200031 (CN)
Priority Data:
00 1 15577.6 29.04.2000 CN
Title (EN) A NEW POLYPEPTIDE - HUMAN DIHYDROORATASE 17 AND THE POLYNUCLEOTIDE ENCODING IT
(FR) NOUVEAU POLYPEPTIDE, DIHYDROOROTASE HUMAINE 17, ET POLYNUCLEOTIDE CODANT POUR CE POLYPEPTIDE
Abstract: front page image
(EN)The present invention discloses a new polypeptide - human dihydroorotase 17, the polynucleotide encoding it and a method of producing the polypeptide by DNA recombinant technology. The present invention further discloses a method treating various disorders, e.g., malignant neoplasm, hematopathy, HIV infection and immunological disease and various inflammation etc. The present invention also discloses an antagonist of the polypeptide and its therapeutic action. The present invention further discloses the use of the polynucleotide encoding the new human dihydroorotase 17.
(FR)L'invention concerne un nouveau polypeptide, une dihydroorotase humaine 17, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la dihydroorotase humaine 17.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)